CI vs CUE
Cigna Corp (CI) versus Cue Biopharma (CUE) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. CUE currently screens at market cap $59.5M.
Not investment advice. Open the CI and CUE stock pages for the full models.
Not investment advice.